Protara Therapeutics (TARA) Invested Capital (2013 - 2020)

Protara Therapeutics (TARA) posted quarterly Invested Capital of $370793.0 for Q3 2020, down 60.0% quarter-over-quarter from $926983.0 in Q2 2020.

Analysis

Protara Therapeutics (TARA) Invested Capital (2013 - 2020) Analysis & Trends

Protara Therapeutics (TARA) has reported Invested Capital for 1 consecutive years, with $370793.0 the latest figure, recorded in Q3 2020.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	33.70 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	7.35 Bn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	6.25 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	19.13 Bn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	1.30 Bn
10	Protara Therapeutics	241.28 Mn	241.28 Mn	-	-

Historic Data

Download Data